Globus Medical Ultrasonic Communication Patent for Adjustable Implants

The USPTO granted patent US12605192B2 to Globus Medical, Inc. and five named inventors. The patent broadly covers ultrasonic frequency communication for establishing transcutaneous data communication between medical devices located on and/or within a patient body, with specific claims related to adjustable implants, hermetic containment, and torque amplification features.

For competitors developing ultrasonic communication systems for medical implants, this grant represents new prior art that may affect freedom-to-operate analyses. Medical device manufacturers working on similar transcutaneous data communication technologies for adjustable implants should evaluate whether their products fall within the scope of the 17 claims granted.